<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thrombopoietin (TPO) serum levels were quantified in patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> using an ELISA test for TPO </plain></SENT>
<SENT sid="1" pm="."><plain>We found that TPO levels were significantly elevated in the whole group of patients as compared with <z:mpath ids='MPATH_458'>normal</z:mpath> healthy donors (521.9 75.3 pg/ml vs 160.1 19.6 pg/ml; P = 0.011) </plain></SENT>
<SENT sid="2" pm="."><plain>TPO serum levels were inversely correlated with the megakaryocyte mass in both the RA/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>/RAEBt subgroups ( P = 0.012 and P = 0.031, respectively) </plain></SENT>
<SENT sid="3" pm="."><plain>Two subsets of patients with a possible dysregulation of TPO production were identified </plain></SENT>
</text></document>